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 The basement membrane is a specialized extracellular matrix substrate responsible for 
support and maintenance of epithelial and endothelial structures. Engineered basement 
membrane-like hydrogel systems have the potential to advance understanding of cell-cell and 
cell-matrix interactions by allowing precise tuning of the substrate or matrix biochemical and 
biophysical properties. In this investigation, we developed tunable hydrogel substrates with 
conjugated bioactive peptides to modulate cell binding and growth factor signaling by endothelial 
cells. Hydrogels were formed by employing a poly(ethylene glycol) crosslinker to covalently 
crosslink gelatin polymers and simultaneously conjugate laminin-derived YIGSR peptides or 
vascular endothelial growth factor (VEGF)-mimetic QK peptides to the gelatin. Rheological 
characterization revealed rapid formation of hydrogels with similar stiffnesses across tested 
formulations, and swelling analysis demonstrated dependency on peptide and crosslinker 
concentrations in hydrogels. Levels of phosphorylated VEGF Receptor 2 in cells cultured on 
hydrogel substrates revealed that while human umbilical vein endothelial cells (HUVECs) 
responded to both soluble and conjugated forms of the QK peptide, conditionally-immortalized 
human glomerular endothelial cells (GEnCs) only responded to the conjugated presentation of 
the peptide. Furthermore, whereas HUVECs exhibited greatest upregulation in gene expression 
when cultured on YIGSR- and QK-conjugated hydrogel substrates after 5 days, GEnCs exhibited 
greatest upregulation when cultured on Matrigel control substrates at the same time point. These 
results indicate that conjugation of bioactive peptides to these hydrogel substrates significantly 
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I. Introduction 
 
 The extracellular matrix (ECM) is composed of proteins, polysaccharides, and other biological 
molecules secreted by resident cells. These components together act as a natural scaffolding 
material that imparts mechanical integrity to tissues and organs as well as presents bioactive 
signals essential for cell and tissue development and maintenance[1, 2]. The ECM is a dynamic 
and highly-hydrated network akin to a stimulus-responsive hydrogel that is tailored to the 
microenvironmental needs of the inhabiting cells[3, 4]. In particular, the basement membrane (BM) 
is a specialized ECM substrate that lies beneath epithelial and endothelial cell populations and 
provides structural support, spatial organization, and bioactive signaling cues to the overlying 
cells[5]. Despite the popularity of naturally-derived materials such as basement membrane extracts 
(e.g., Matrigel) for studying complex cell-cell and cell-matrix interactions, often times these 
materials are limited by lot-to-lot variability and the inability to precisely tune material properties[6]. 
 
 The objective of this investigation was to engineer a hydrogel substrate capable of mimicking 
properties of the BM specifically to explore endothelial cell-cell and cell-matrix interactions. To 
accomplish this, we employed a versatile approach to generate hydrogels from both synthetic and 
natural polymer sources with tunable stiffness, termed the PEGX method[7]. The method utilizes 
a poly(ethylene glycol) (PEG) crosslinker, or PEGX, to form covalent crosslinks between available 
reactive groups on the polymers resulting in a stable network and hydrogel formation. Hydrogel 
stiffness may be modulated by varying the polymer concentration or the amount of crosslinker 
added, and the crosslinking method can be extended to a variety of different physical and 
chemical PEGX variants[7].  
 
 Gelatin was chosen as the base polymer for the hydrogels. Though not generally considered 
a BM component, gelatin is an accessible and economical biomaterial that has been employed in 
numerous biomedical applications, such as vehicles for drug delivery, scaffolds for tissue 
engineering, and hydrogels for 3D matrix cultures[8-10]. Because gelatin is derived from collagen, 
it retains key bioactive peptide sequences such as cell-binding sites (e.g., RGD) and matrix 
metalloproteinase-sensitive degradation motifs. To specifically tailor the bioactivity of these 
hydrogel substrates to better mimic the BM of endothelial cells, we sought to incorporate peptide 
sequences known to modulate endothelial cell behavior. We further hypothesized that the desired 
peptides could be conjugated to the gelatin polymer through the use of additional PEGX, resulting 
in a covalent link that would lead to prolonged residence time, as opposed to simple encapsulation 
of the peptides within the hydrogels, and therefore extend availability for signaling pathway 
activation. Two peptides of significant interest for examining the effects on endothelial cells are 
the laminin-derived YIGSR peptide and the vascular endothelial growth factor (VEGF)-mimetic 
QK peptide. 
 
 The YIGSR peptide is derived from the 1 chain of laminin, a major component of the BM[5], 
and was discovered to mediate cell adhesion and migration through binding of the 67-kDa laminin 
receptor[11, 12]. Research by other groups demonstrated that modification of polyurethaneurea 
films and scaffolds with YIGSR peptides enhanced endothelial attachment and reduced platelet 
adhesion[13-15]. Interestingly, in combination with RGD peptides, YIGSR peptides inhibited 
endothelial growth on self-assembled peptide hydrogels[16]. However, additional investigations 
showed that covalent attachment of RGD and YIGSR peptides to PEG acrylate/diacrylate 
hydrogels enhanced endothelial cell migration[17] and tubulogenesis[18]. 
 
 The QK peptide is a VEGF-mimetic peptide first designed by D’Andrea, et al. and confirmed 
to bind and activate VEGF Receptor 1 (VEGFR1 or Flt-1) and VEGF Receptor 2 (VEGFR2 or 
KDR)[19]. VEGF signaling is important in a variety of physiological contexts, but it is especially 
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critical in the development of new blood vessels and maintenance of healthy vasculature and 
endothelial function[20]. Furthermore, heparan sulfate proteoglycans, another major component of 
the BM, are known to bind and sequester growth factors including specific VEGF isoforms[5]. 
However, in contrast to large growth factors such as recombinant VEGF, the use of short, 
bioactive peptide mimetics is advantageous due to their smaller size, decreased chemical 
complexity, and reduced production costs[21]. The QK peptide consists of 15 natural amino acids 
and is likely named for the first and last residues that constitute the peptide’s helical region (the 
sequence between residues 4 and 12 of the peptide) and correspond to the -helix region of 
VEGF[19]. Research by other groups demonstrated that the QK peptide stimulated endothelial 
growth when tethered to elastin-like peptide hydrogels[22], promoted endothelial network formation 
when incorporated into type I collagen coatings[23], and enhanced endothelial tube-like structure 
formation when conjugated to PEG diacrylate[24] and gelatin methacrylate[25] hydrogels. 
 
 In this work, we developed crosslinked gelatin hydrogels with conjugated YIGSR and QK 
peptides using the PEGX method and evaluated these hydrogels as BM-like substrates for 
endothelial cell culture. Successful crosslinking of the gelatin polymers and conjugation of the 
YIGSR and QK peptides was determined by measuring the available reactive groups remaining 
after the crosslinking reaction. Rheology was performed to observe hydrogel crosslinking kinetics 
and measure the rheological properties (i.e., shear moduli) of the hydrogels. Scanning electron 
microscopy and swelling analysis revealed the ultrastructural and swelling characteristics of the 
hydrogels, respectively. For cell culture studies, we employed human umbilical vein endothelial 
cells (HUVECs) and conditionally-immortalized human glomerular endothelial cells (GEnCs). 
Intracellular levels of phosphorylated VEGFR2 in response to treatment with soluble QK peptide 
or culture on QK-conjugated hydrogels was measured to assess the bioactivity of the peptide. 
Finally, gene expression of cells cultured on hydrogel substrates was evaluated at multiple 
timepoints. 
 
II. Material & Methods 
 
2.1. Peptide Synthesis and Determination of Peptide Concentrations for Experiments 
QK, YIGSR, and RYGSI (scrambled YIGSR peptide control) peptides were purchased through 
custom peptide synthesis from ABI Scientific and confirmed to have a purity of >95% by high-
performance liquid chromatography. Peptide sequences are listed in Table 1. Lysine ε-amino 
groups were acetylated to prevent cross-reactivity with the amine-reactive PEGX. C-termini of 
peptides were amidated to enhance stability, but N-termini were left unmodified. Peptides were 
solubilized in 1× phosphate-buffered saline solution (PBS, pH 7.4, Gibco, #10010) as 
concentrated stock solutions and frozen in aliquots at -20 °C. Aliquots were thawed and diluted 
as necessary for hydrogel preparation. Hydrogel formulations containing a range of peptide 
concentrations (QK and/or YIGSR) were devised based on evaluations of literature investigations. 
Previous studies exploring the bioactivity of the QK peptide and incorporation of the QK peptide 
into other hydrogel systems tested concentrations ranging from 1 µM to 100 µM and greater[19, 23-
25]. Therefore, we selected QK peptide concentrations of 0, 1, 10, and 100 µM to evaluate its effect 
on endothelial cells when conjugated to hydrogels using the PEGX method. A study investigating 
conjugation of the YIGSR peptide into PEG diacrylate hydrogels used a concentration of 3.5 
mM[18]. Another study incorporating the YIGSR peptide into self-assembling peptide hydrogels 
found optimal HUVEC growth at a concentration of 6 mM[16]. Therefore, we selected YIGSR 
concentrations of 0, 3, 6, and 12 mM to evaluate its effect on endothelial cells when conjugated 
to hydrogels using the PEGX method. 
 
Table 1: Peptide Sequences 
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where (K-Ac) indicates acetylation of the lysine ε-amino group 
2036.31 
YIGSR YIGSR 593.68 
RYGSI RYGSI 593.68 
 
2.2. Preparation of Hydrogels and Phase Analysis 
The general strategy for the preparation of PEG-crosslinked gelatin hydrogels with conjugated 
peptides is outlined in Scheme 1. Gelatin type A (Sigma, #G1890) was solubilized in PBS at 37 °C 
at a stock concentration of 10% (m/v). Hydrogel precursor polymer solutions were prepared by 
mixing the following in order: PBS for dilution, 1 M NaOH (Sigma, #S2770) to buffer solutions to 
an approximate final pH of 6 for optimal crosslinking kinetics, peptides (if desired), and gelatin 
stock solution. Polymer solutions were held at 37 °C prior to crosslinking to ensure solution phase 
and thoroughly vortexed before the addition of crosslinker. Homobifunctional poly(ethylene glycol) 
succinimidyl valerate (SVA) (MW 5000 g/mol, Laysan Bio), referred to as simply PEG crosslinker 
or PEGX, was prepared as a concentrated stock solution at 40 mM in PBS just prior to crosslinking 
of polymer solutions. Immediately after adding PEGX to hydrogel precursor polymer solutions, 
solutions were vortexed, pipetted into well plates or molds as necessary, and incubated at 37 °C 
for 2 hrs. Main hydrogel formulations investigated are listed in Table 2. For phase analysis and 
phase plot generation, hydrogel formulations were prepared in microcentrifuge tubes. After the 2 
hr incubation period, phase of formulations, either solution (sol) or hydrogel (gel), was determined 
by tube inversion, and those determined to be gel phase were manipulated with a spatula to 
qualitatively gauge hydrogel stiffness. Hydrogels that could be easily spread were designated as 
“soft”, and those that retained their shape were designated as “robust”[7]. 
 
Table 2: Main Hydrogel Formulations Tested 




Gelatin, % (m/v) 5.0 5.0 5.0 5.0 5.0 
QK (µM) 0.0 100.0 0.0 100.0 0.0 
YIGSR (mM) 0.0 0.0 12.0 12.0 0.0 
RYGSI (mM) 0.0 0.0 0.0 0.0 12.0 
PEGX (mM) 1.55 1.60 7.95 8.00 7.95 
PEGX:Gelatin (m:m) 0.155 0.160 0.795 0.800 0.795 
 
2.3. Quantification of Free Amine Content 
 Free amine content of hydrogel precursor polymer solutions and crosslinked hydrogels were 
quantified by the 2,4,6-trinitrobenzenesulfonic acid (TNBS) assay and performed according to 
previously published studies[7, 26, 27]. TNBS working solution was prepared fresh by diluting stock 
solution (picrylsulfonic acid solution, Sigma, #P2297) to a concentration of 0.01 M with a 4% (m/v) 
sodium bicarbonate solution (Sigma, #S5761), pH 8.5 prepared in deionized H2O. A volume of 
500 µL TNBS working solution was added to freshly-prepared 50-µL hydrogel precursor polymer 
solutions and crosslinked hydrogels, and samples were incubated at 37 °C for 2 hrs. To stop 
reactions, 500 µL of 10% (m/v) sodium dodecyl sulfate (Sigma, #L3771) prepared in deionized 
H2O and 250 µL of 1 M HCl (Sigma, #H9892) were added to samples. Samples were then allowed 
to hydrolyze overnight at 37 °C. Samples were diluted as necessary in deionized H2O, and 200 
 
2019_PEGX-Gelatin_Peptides_Manuscript_Draft14 
Document Created: 2019-01-19 (JS) 
Last Updated: 2019-01-23 (JS) 
6 
Jimmy Su (JS) 
µL per sample was transferred to a clear 96-well plate. Absorbance at 335 nm (A335) was 
measured on a BioTek Cytation 3 Cell-Imaging Multi-Mode Reader. Samples were tested in 
triplicate (n = 3) with technical replicates in duplicate, compared to a standard curve of L-leucine 
(Sigma, #L8000), and normalized to the uncrosslinked control group of 5% (m/v) gelatin solution 
with no peptides. 
 
2.4. Rheological Characterization and pH Measurement 
Rheological characterization of hydrogels was performed following a recommended protocol 
for hydrogels for tissue engineering applications[28]. Testing was performed using an Anton Paar 
MCR 302 rheometer with a 25-mm 2°-angle cone-plate fixture under strain-controlled conditions. 
The lower Peltier cell was set to 37 °C and allowed to equilibrate prior to sample loading. All 
samples were mixed fresh and immediately loaded onto the rheometer stage. Once the 
measuring system was lowered, mineral oil (Amresco, #J217) was applied to the edges of the 
fixture and sample, and the entire system was enclosed within a solvent trap to prevent sample 
dehydration. Time sweeps were performed for 2 hrs at 37 °C, 1% strain, and 10 rad/s. Frequency 
and strain sweeps were performed immediately following under the same conditions. After sample 
loading, the pH of excess sample volume remaining was measured using a VWR sympHony 
SB70P pH meter with a Thermo Scientific Orion PerpHecT ROSS Combination pH Micro 
Electrode. All samples were tested in triplicate (n = 3). 
 
2.5. Scanning Electron Microscopy (SEM) 
 Hydrogels were fixed in 2% (v/v) glutaraldehyde (Sigma-Aldrich, #G7776) and 3% (m/v) 
sucrose (J. T. Baker, #4072) in 1× PBS and pH 7.4 for 1 hr at 4 °C. Samples were dehydrated in 
a graded ethanol series (30-100% in MilliQ H2O, Decon Laboratories, #2701) of 15 min. intervals 
and critical-point dried in a Tousimis SAMDRI-790 Critical Point Dryer. For low-magnification 
SEM, samples were sputter coated with ~10 nm of Au using a Baltec MED-020 Coating System 
and imaged on a JEOL NeoScope JCM-6000PLUS. For high-magnification SEM, samples were 
coated with ~9 nm of Os using an SPI Supplies Osmium Plasma Coater OPC-60A and imaged 
on a Hitachi S-4800 Type II field emission SEM. 
 
2.6. Swelling Analysis 
 Hydrogel precursor polymer solutions plus PEGX were prepared, and 100 µL of polymer 
solution was cast into 8-mm diameter cylindrical silicone molds (Grace Bio-Labs). After the 2 hr 
incubation period, crosslinked hydrogels were carefully removed from molds, and the initial 
weights (Winitial) of samples were recorded. Samples were then allowed to equilibrate in 3 mL PBS 
per sample for 24 hrs at 37 °C. After equilibration, samples were removed from PBS, lightly blotted 
with filter paper, and weighed. The new equilibrated or swollen wet weights (Wwet) of samples 
were recorded. Samples were then frozen at -80 °C and lyophilized overnight on a VirTis 
adVantage Plus EL-85, and the dry weights (Wdry) of samples were recorded. The percent weight 
increase and swelling ratio of hydrogels were calculated as follows: 
% 𝑤𝑒𝑖𝑔ℎ𝑡 𝑖𝑛𝑐𝑟𝑒𝑎𝑠𝑒 =  
𝑊𝑤𝑒𝑡  − 𝑊𝑖𝑛𝑖𝑡𝑖𝑎𝑙
𝑊𝑖𝑛𝑖𝑡𝑖𝑎𝑙
∗ 100% 




All samples were weighed on a Mettler Toledo XP105DR Excellence Plus analytical balance, and 
the sample size was six hydrogels for each group (n = 6). 
 
2.7. Cell Culture 
 Human umbilical vein endothelial cells (HUVECs) were purchased from Lifeline Cell 
Technology (normal primary, #FC-0003) and cultured in Endothelial Growth Medium-2 (EGM-2 
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BulletKit, Lonza, #CC-3162) containing 2% fetal bovine serum (FBS) and growth factors as 
supplied with the exception of VEGF. Growth factor supplements included: epidermal growth 
factor, fibroblast growth factor β, R3-insulin-like growth factor-1, ascorbic acid, hydrocortisone, 
heparin, and gentamicin and amphotericin-B. Cells were cultured at 37 °C in 5% CO2, media was 
exchanged every other day, and cells were used between passages 3 and 5 for experimental 
studies. Conditionally-immortalized human glomerular endothelial cells (GEnCs) were cultured as 
described previously[29]. These are primary cells that have been transfected with a temperature-
sensitive SV40-T antigen and the essential catalytic subunit of human telomerase (hTERT) to 
prevent replicative senescence[29, 30]. Culture at the permissive temperature of 33 °C results in 
active expression of the transgenes to maintain an immature cell state and allow proliferation of 
the cells. Thermoswitching to the non-permissive temperature of 37 °C results in inactivation of 
the transgenes, causing the cells to become quiescent and adopt a more mature phenotype that 
is comparable to freshly isolated GEnCs[29]. GEnCs were cultured in Microvascular Endothelial 
Growth Medium-2 (EGM-2 MV BulletKit, Lonza, #CC-3202) containing 5% FBS and growth 
factors as supplied with the exception of VEGF. Growth factor supplements included: epidermal 
growth factor, fibroblast growth factor β, R3-insulin-like growth factor-1, ascorbic acid, 
hydrocortisone, and gentamicin and amphotericin-B. Media was exchanged every other day, and 
cells were used at passage 30 or below for experimental studies. 
 
2.8. Cell Experimental Studies 
Experimental studies involving cell culture on hydrogel substrates were performed in a similar 
manner as previously-established endothelial cell tube formation assays[31, 32]. Hydrogel precursor 
polymer solutions plus PEGX were prepared and cast in well plates, 165 µL/cm2, and allowed to 
incubate for 2 hrs at 37 °C prior to plating of cells. Matrigel Basement Membrane Matrix (Phenol 
Red-Free, Corning, #356237) served as an additional control for cell experimental studies. 
Matrigel was thawed on ice, cast in well plates, and incubated alongside experimental groups. 
Cells were then prepared for plating: cells were rinsed once with 1× Dulbecco’s phosphate-
buffered saline (DPBS, Mediatech, #21-030), lifted with TrypLE Express (Gibco, #12605) at 37 °C, 
collected and counted via the trypan blue exclusion method using Trypan Blue solution (Sigma, 
#T8154), centrifuged, and resuspended in complete media. Cells were plated on substrates at an 
approximate final density of 48,000 cells/cm2, and well plates were transferred to a 37 °C 
incubator at 5% CO2. At designated time points, photomicrographs of samples were captured on 
a Lumenera INFINITY1-3C microscopy camera mounted on a Nikon Eclipse TS100 using 
Lumenera INFINITY ANALYZE 6.5 software. 
 
2.9. VEGFR2/KDR Phosphorylation Assay 
Phosphorylated VEGFR2 was quantified with the Human Phospho-VEGF R2/KDR DuoSet IC 
ELISA (R&D Systems, #DYC1766) kit. GEnCs were expanded at 33 °C, plated on culture 
substrates three days prior to treatment, and cultured at 37 °C after plating. HUVECs were plated 
on culture substrates two days prior to treatment and cultured at 37 °C. Both HUVECs and GEnCs 
were fully confluent prior to treatment and sample collection. Cells were serum deprived overnight 
in Endothelial Basal Medium-2 (EBM-2, Lonza, #CC-3156) plus 1% FBS (Gibco, #16000) and 1% 
penicillin-streptomycin (Gibco, #15140) prior to treatment and then serum starved in EBM-2 plus 
1% penicillin-streptomycin for 5 hrs prior to treatment. Cells were treated with one of the following 
soluble factors for 5 min. at 37 °C: no treatment (negative control), 100 ng/mL recombinant human 
VEGF-165 (~5.2 µM, R&D Systems, #293-VE-010/CF) (positive control), 1 µM soluble QK 
peptide, or no treatment for cells cultured on QK hydrogels (hydrogels conjugated with 100 µM of 
QK peptide). After treatment, cells were rinsed twice with DPBS and collected with Lysis Buffer 
#9 composed of Sample Diluent Concentrate 2 (R&D Systems, #DYC002), 10 µg/mL aprotinin 
(Tocris, #4139), and 10 µg/mL leupeptin (Tocris, #1167) following the kit recommendations. Cell 
lysates were frozen at -80 °C until assayed following the manufacturer’s protocol, and sample 
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absorbance at 450 nm (A450) corrected by absorbance at 540 nm (A540) was measured on a 
BioTek Synergy 2 Multi-Mode Microplate Reader. Biological replicates were tested in 
quadruplicate (n = 4) with technical replicates in duplicate. Samples were compared to a standard 
curve of Human Phospho-VEGF R2/KDR Control provided by the manufacturer and normalized 
to negative (no treatment, tissue culture polystyrene substrates) control groups for each cell type. 
 
2.10. Gene Expression Analysis 
 RNA was isolated from samples and cell pellets using TRIzol Reagent (Invitrogen, #15596) 
following the manufacturer’s protocol. Isolated RNA was treated with DNA-free DNA Removal Kit 
(Ambion, #1906) to remove contaminating genomic DNA from samples. RNA concentration was 
measured using a NanoDrop 1000 Spectrophotometer (Thermo Scientific). Reverse transcription 
and cDNA synthesis was performed using iScript Reverse Transcription Supermix for RT-qPCR 
(Bio-Rad, #170-8841) with an Applied Biosystems GeneAMP PCR System 9700 following the 
manufacturer’s protocol. Real-time quantitative polymerase chain reaction was performed using 
SsoAdvanced Universal SYBR Green Supermix (Bio-Rad, #170-5270) with an Applied 
Biosystems QuantStudio 7 Flex Real-Time PCR System. Primer sequences for genes of interest 
are listed in Supplemental Table 1. The thermal profile used included an initial polymerase 
activation step at 95 °C for 30 sec. followed by 40 amplification cycles of denaturation at 95 °C 
for 15 sec. and annealing and extension at 60 °C for 60 sec. The expression of each gene of 
interest was normalized to expression of the housekeeping gene cyclophilin A (PPIA), and the 
relative degree of gene amplification was calculated using the ΔΔCT method: 2[(CT GOI 2 - CT PPIA 2) - 
(CT GOI 1 - CT PPIA 1)]. “CT GOI 1” represents the threshold cycle (CT) of the gene of interest of the 
reference population, and “CT GOI 2” represents the gene of interest of the experimental sample. 
Day 0 HUVECs cultured on tissue culture polystyrene served as the reference population for 
HUVEC samples, and day 0 GEnCs cultured on tissue culture polystyrene served as the 
reference population for GEnC samples. Biological replicates were tested in quadruplicate (n = 4) 
with technical replicates in triplicate. 
 
2.11. Immunofluorescence 
 Samples were rinsed once with DPBS and fixed with 4% paraformaldehyde (Alfa Aesar, 
#43368) in DPBS for 12 min. at room temperature after which fixative was replaced with fresh 
DPBS, and samples were stored at 4 °C until staining. To perform whole-mount 
immunofluorescence staining, fixed samples were carefully removed from well plates and 
transferred to microcentrifuge tubes. Samples were rinsed once with PBS, permeabilized with 
0.1% Triton X-100 (Amresco, #0694) in PBS (PBST) for 10 min., and then blocked with Sea Block 
(Fisher Scientific, #37527) for 30 min. to 1 hr. Primary antibodies were diluted in Sea Block as 
follows: mouse anti-PECAM-1 at 1:100 (Abcam, #ab187377) and rabbit anti-VEGFR2 at 1:200 
(Cell Signaling Technology, #2479). Samples were incubated with primary antibodies for 1 hr at 
room temperature, rinsed three times with PBST, blocked with Sea Block for an additional 5 min., 
and then incubated with secondary antibodies for 1 hr at 37 °C. Secondary antibodies were diluted 
in Sea Block as follows: goat anti-mouse Alexa Fluor 488 at 1:300 (Thermo Fisher, #A11029) and 
goat anti-rabbit Alexa Fluor 555 at 1:300 (Thermo Fisher, #A21429). After secondary antibody 
incubation, samples were rinsed three times with PBST, rinsed once with PBS, and mounted 
between #1.0 glass coverslips (Fisher Scientific, #12-542-B) with Mowiol mounting medium 
containing 4’,6-diamidino-2-phenylindole (DAPI) to stain for cell nuclei. Whole-mount samples 
were imaged on a Nikon A1 Confocal Laser Microscope System. 
 
2.12. Statistical Analysis 
All quantitative data is represented as the mean ± standard error of the mean. Statistical 
significance was determined using an unpaired two-tailed Student’s t-test assuming equal 
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variance with Microsoft Excel (Microsoft). Significance for all statistical analyses was defined as 




3.1. Optimization of Peptide and PEGX Concentrations 
 
 A higher concentration of PEGX was required to adequately conjugate YIGSR peptides to the 
gelatin polymers at millimolar concentrations and ensure formation of stable hydrogel substrates 
that would not rapidly degrade in cell culture conditions. Phase analysis of formulations and the 
resulting phase plot depicts the necessary PEGX concentrations to generate increasingly stiffer 
hydrogels with conjugated YIGSR concentrations of interest (Supplemental Figure 1). 
Rheological characterization of specific formulations aided in selecting precise PEGX 
concentrations to generate robust hydrogels of similar stiffness. Hydrogel formulations selected 
for the following initial cell experiment possessed final storage moduli of ~200-250 Pa. 
 
 Hydrogel substrates with varying combinations and concentrations of YIGSR and QK peptides 
(total of sixteen combinations) were prepared for cell culture to determine optimal peptide 
concentrations that elicited a discernible cell response. Matrigel was included as an additional 
group for comparison. GEnCs were plated on hydrogel substrates, and cells were observed in 
culture over time by optical microscopy. Cells cultured on hydrogels conjugated with 12 mM 
YIGSR peptide began to form cord-like structures after several hours. After 24 hrs in culture, cells 
cultured on YIGSR-conjugated hydrogels exhibited cord-like structure formation with branching 
structures occurring more frequently on hydrogels conjugated with 6 or 12 mM YIGSR peptide 
(Supplemental Figure 2). At the same time, GEnCs also formed smaller yet distinctively 
apparent cord-like structures on hydrogels conjugated with 10 and 100 µM QK peptide with 
consistently larger structures forming on hydrogels conjugated with 100 µM QK peptide in 
comparison to those conjugated with only 10 µM QK peptide (Supplemental Figure 2). 
Therefore, in subsequent investigations, the maximum tested peptide concentrations were 
chosen, that is 100 µM QK peptide and 12 mM YIGSR peptide (Table 2), as these concentrations 
elicited the greatest and most rapid cell response in this initial experiment. 
  
3.2. Quantification of Free Amine Content  
 
Table 3: Free Amine Content of Hydrogel Precursor Polymer Solutions and Crosslinked Hydrogels 
Sample No Peptides QK YIGSR YIGSR/QK 
Uncrosslinked     
Normalized Free Amine Content 1.00 ± 0.03 1.03 ± 0.04 1.50 ± 0.03 1.52 ± 0.06 
Plus PEGX     
Normalized Free Amine Content 0.77 ± 0.03 0.79 ± 0.09 0.63 ± 0.02 0.70 ± 0.07 
% Reacted Amines 23.30 ± 3.06 23.52 ± 8.58 57.84 ± 0.49 54.17 ± 4.94 
 
 Quantification of free amine content of hydrogel precursor polymer solutions via the TNBS 
assay demonstrated that, compared to hydrogel formulations with no peptides, addition of 100 
µM QK peptide resulted in only a slight increase of free amine content whereas addition of 12 mM 
YIGSR peptide resulted in a larger increase of 50% in free amine content (Table 3 and Figure 
1A). The addition of the amine-reactive PEGX to crosslink polymer solutions and form hydrogels 
resulted in a reduction of free amine content for all groups. This reduction corresponded to 20-
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25% reacted amines for hydrogels with no peptides and QK hydrogels and 50-60% reacted 
amines for YIGSR and YIGSR/QK hydrogels (Table 3 and Figure 1A). 
 
3.3. Rheological Characterization and pH Measurements 
 
Table 4: pH and Rheological Characterization of Hydrogels 
Sample No Peptides QK YIGSR YIGSR/QK 
pH 6.13 ± 0.01 6.08 ± 0.01 5.87 ± 0.01 5.85 ± 0.01 
G'-G'' Crossover (min) 10.5 ± 0.60 12.3 ± 0.31 6.5 ± 0.18 4.7 ± 0.24 
Storage Modulus, G' at 2 hrs (Pa) 198.65 ± 3.57 197.68 ± 15.68 201.02 ± 8.36 214.47 ± 28.89 
Loss Modulus, G'' at 2 hrs (Pa) 1.95 ± 0.05 2.05 ± 0.08 3.00 ± 0.03 2.88 ± 0.09 
Complex Shear Modulus, G at 2 hrs 
(Pa) 
198.66 ± 3.57 197.69 ± 15.68 201.04 ± 8.36 214.49 ± 28.89 
 
 Rheological characterization revealed changes in shear moduli (G’, G’’) during hydrogel 
formation. Shear moduli measurements are listed in Table 4 and include the storage modulus 
(G’) and loss modulus (G’’) crossover point and the storage, loss, and complex shear moduli at 2 
hrs. In addition, pH measurement of formulations immediately after addition of PEGX indicate that 
all formulations fell within a pH range from 5.85 to 6.15 (Table 4). Time sweeps demonstrate 
sigmoidal gelation profiles for all hydrogel formulations (Figure 1B-E) with G’-G’’ crossover points 
between 4.5 and 12.5 min. (Table 4) indicating rapid formation of hydrogels after the addition of 
PEGX. Shear moduli began to stabilize around 1 hr, and final storage and complex shear moduli 
at 2 hrs for all hydrogels ranged between 195 and 215 Pa (Table 4). Frequency sweeps revealed 
that the G’ of all hydrogels were relatively independent of the frequencies tested, and the angular 
frequency value employed for time sweeps was verified to be in the low-frequency plateau region 
for all formulations (Supplemental Figure 3A-D). Strain or amplitude sweeps revealed that the 
shear moduli of all hydrogels were independent of strain up until 100% strain (the linear 
viscoelastic region) after which hydrogels exhibited strain-stiffening behavior and catastrophic 
failure at approximately 1000% strain (Supplemental Figure 3E-H). 
 
3.4. Scanning Electron Micrographs and Swelling Analysis of Hydrogels 
 
 At low magnifications, scanning electron microscopy revealed relatively flat, homogeneous 
surfaces for all hydrogels (Supplemental Figure 4). At higher magnifications, hydrogels exhibited 
a porous yet relatively unstructured and amorphous ultrastructure (as opposed to a fibrillar one) 
(Figure 2A-D). Analysis of hydrogels between initial and swollen states demonstrated that 
hydrogels with no peptides and QK hydrogels exhibited similar percent weight increases of 115.42 
± 4.94 and 120.98 ± 1.49, respectively, whereas YIGSR and YIGSR/QK hydrogels exhibited much 
greater percent weight increases of 209.30 ± 5.42 and 220.94 ± 2.18, respectively (Figure 2E). 
However, analysis of swelling ratios, that is the ratio of wet to dry weight of samples, revealed 
that all of the hydrogels exhibited similar swelling ratios between 32 and 35 (Figure 2F). 
 
3.5. QK Peptide Bioactivity and Phosphorylation of VEGFR2 in HUVECs and GEnCs 
 
 To ensure that the QK peptide was indeed bioactive in the soluble form and that this bioactivity 
was preserved after conjugation, an ELISA specific to phosphorylated VEGFR2 was used to 
measure cellular levels of activated and phosphorylated VEGFR2 in response to the QK peptide. 
Treatment of HUVECs with either soluble VEGF165 or soluble QK peptide resulted in significantly 
increased levels of phosphorylated VEGFR2 relative to untreated controls for HUVECs cultured 
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on tissue culture polystyrene or on hydrogels with no peptides (Figure 3A). HUVECs cultured on 
QK hydrogels also resulted in significantly increased levels of phosphorylated VEGFR2 relative 
to HUVECs cultured on hydrogels with no peptides (Figure 3A). Surprisingly, treatment of GEnCs 
with either soluble VEGF165 or soluble QK peptide did not result in significant changes in levels of 
phosphorylated VEGFR2 relative to untreated controls, and this was consistent for both GEnCs 
cultured on tissue culture polystyrene or on hydrogels with no peptides (Figure 3B). In contrast, 
however, GEnCs cultured on QK hydrogels resulted in significantly increased levels of 
phosphorylated VEGFR2 relative to GEnCs cultured on hydrogels with no peptides (Figure 3B). 
 
3.6. HUVEC Culture, Gene Expression Analysis, and Immunofluorescence 
 
 HUVECs were plated on hydrogel substrates and cultured for up to 5 days (Figure 4). For cell 
culture experiments, Matrigel served as positive control because it is commonly utilized in 
endothelial cell tube formation and angiogenesis assays[31, 32]. RYGSI hydrogels served as an 
additional scrambled YIGSR peptide control to account for the increased concentration of PEGX 
necessary in YIGSR and YIGSR/QK hydrogel formulations. On Matrigel, HUVECs underwent 
rapid morphogenesis and formed an interconnected network within 6 hrs that began to regress 
by 24 hrs and was completely absent after 3 days though cell aggregates could be observed at 
the sides of wells. On hydrogels with no peptides, HUVECs proliferated to form a monolayer 
approximately 60-70% confluent by 24 hrs, and cells continued to proliferate resulting in the cord-
like structures observed at day 3 and beyond. On QK hydrogels, a similar response was observed 
as HUVECs cultured on hydrogels with no peptides. On YIGSR hydrogels, HUVECs began to 
form cord-like structures by 6 hrs that increased in size and connections by 24 hrs, but cells did 
not form a confluent monolayer by day 5, and instead the network formed by the cord-like 
structures appeared to tighten. On YIGSR/QK hydrogels, a similar response was observed as 
HUVECs cultured on YIGSR hydrogels. On RYGSI hydrogels, HUVECs began to form cord-like 
structures by 6 hrs in a similar manner as on YIGSR and YIGSR/QK hydrogels; however, cells 
continued to proliferate and formed a confluent monolayer by day 3 with cord-like structures still 
present. 
 
 Genes of interest included in gene expression analysis are involved in cell-cell interactions 
(PECAM1, CDH5/VE-Cad), cell-matrix interactions via integrins (ITGB1, ITGB3), signaling 
pathways via cell surface receptors (KDR/VEGFR2, TEK/TIE2), and endothelial function (VWF, 
NOS3, PLVAP) (Figure 5). In general, gene expression analysis revealed highest fold-change 
expression by HUVECs cultured on YIGSR/QK hydrogels at day 5 (Figure 5A-I). This is true for 
CDH5 (Figure 5B), ITGB3 (Figure 5D), KDR (Figure 5E), TEK (Figure 5F), VWF (Figure 5G), 
and NOS3 (Figure 5H). For PECAM1 (Figure 5A) and ITGB1 (Figure 5C), HUVECs exhibited 
greatest upregulation on QK hydrogels at 24 hrs, and for PLVAP (Figure 5I), HUVECs exhibited 
greatest upregulation on Matrigel at 24 hrs. HUVECs cultured on RYGSI hydrogels generally 
exhibited the lowest fold-change expression of genes compared to other groups at all time points. 
Immunofluorescence staining confirmed the expression of platelet endothelial cell adhesion 
molecule (PECAM-1 or CD31 encoded by PECAM1) and of VEGFR2 (encoded by KDR) by 
HUVECs cultured on no peptide, QK, YIGSR, and YIGSR/QK hydrogels at 6 and 24 hrs (Figure 
5J). 
 
3.7. GEnC Culture and Gene Expression Analysis 
 
 GEnCs were similarly plated on hydrogel substrates and cultured for up to 5 days at the non-
permissive temperature (Figure 6). On Matrigel, GEnCs underwent rapid morphogenesis and 
formed an interconnected network within 6 hrs that rapidly regressed by 24 hrs, and by 3 days 
only large cell aggregates remained. On hydrogels with no peptides, GEnCs proliferated slowly 
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as the transgenes began to degrade resulting in a fully confluent and stable monolayer on days 
3 and 5. On QK hydrogels, GEnCs proliferated in a similar manner as on hydrogels with no 
peptides; however, this proliferation resulted in the formation of cord-like structures not seen on 
hydrogels with no peptides at day 5. On YIGSR hydrogels, GEnCs began to form cord-like 
structures by 6 hrs that continued to form connections over the culture period; however, the cells 
did not form a confluent monolayer by day 5 and appear morphologically distinct compared to the 
cord-like structures formed by HUVECs on the same hydrogels (Figure 4). On YIGSR/QK 
hydrogels, a similar response was observed as GEnCs cultured on YIGSR hydrogels. On RYGSI 
hydrogels, GEnCs began to form cord-like structures by 6 hrs in a similar manner as on YIGSR 
and YIGSR/QK hydrogels; however, cells were not homogeneously distributed across the 
hydrogel and instead clustered towards the center of the well, which resulted in the formation of 
a confluent monolayer in the center of the well by day 5 and cord-like structures that present as 
denser in appearance. 
 
 Gene expression analysis results of GEnC cultures were generally more varied than results 
from HUVEC cultures, and fold-change expression by GEnCs was generally lower than HUVECs 
(Figure 7). GEnCs exhibited greatest fold-change expression on Matrigel at day 5 for PECAM1 
(Figure 7A), CDH5 (Figure 7B), KDR (Figure 7E), TEK (Figure 7F), VWF (Figure 7G), and 
PLVAP (Figure 7I). In addition, GEnCs cultured on RYGSI hydrogels exhibited high fold-change 
expression of genes such as PECAM1, CDH5, and ITGB3 (Figure 7D) at day 5 and ITGB1 




 The BM, a structure composed of layered ECM molecules, underlies epithelial and endothelial 
cell populations and provides a dynamic interface between these cells and the surrounding 
parenchyma[5]. Recapitulating the unique properties of the BM using synthetic biomaterial 
systems, such as hydrogel matrices, requires careful modulation of the system’s physicochemical 
properties[6]. In this work, we employed a versatile chemical crosslinking strategy, the PEGX 
method, to generate stable gelatin hydrogels for cell culture while simultaneously conjugating 
synthetic peptides to the gelatin polymer backbone to impart additional bioactivity. The two 
peptides of interest for these investigations were the laminin-derived YIGSR peptide[11, 12] and the 
VEGF-mimetic QK peptide[19]. Material characterization of the hydrogel formulations included 
rheological, ultrastructural, and swelling analyses, and in vitro studies with HUVECs and GEnCs 
were performed to evaluate performance of the hydrogels as a BM mimic for endothelial cell 
culture. 
 
 Hydrogels are highly hydrated, crosslinked networks of polymers. In the current investigation, 
the formation of a hydrogel from a precursor polymer solution occurs when the PEGX SVA 
functional groups react with free amines present on the gelatin polymers resulting in a covalently-
crosslinked gelatin network (Scheme 1). Using this system, hydrogels can be additionally 
functionalized with bioactive molecules containing free amine groups such as synthetic peptides. 
Quantification of the free amine content of hydrogel precursor polymer solutions and crosslinked 
hydrogels via the TNBS assay confirmed that crosslinking occurs as a result of the PEGX reacting 
with free amine groups (Figure 1A). As expected, the percentage of reacted amines for the 
hydrogels with no peptides (Table 3) was similar in range to results presented in a previously 
published investigation demonstrating the utility the PEGX method[7]. Furthermore, the addition of 
the YIGSR peptide at a concentration of 12 mM increased the free amine content of the respective 
hydrogel precursor polymer solutions to approximately 1.5 times that of polymer solutions with no 
peptides, and addition of PEGX resulted in normalized free amine content values below that of 
crosslinked hydrogels with no peptides. This indicates that both successful crosslinking between 
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gelatin polymers as well as conjugation of the YIGSR peptide to the gelatin polymer network 
occurred. It is possible that other products will result from the crosslinking reaction, such as the 
reaction of a single PEGX molecule with two peptides; however, we expect these products to 
occur at a much lower frequency than the desired conjugation of peptides to the gelatin polymers 
due to the greater availability of free amines on the gelatin. 
 
 Successful crosslinking of the hydrogel precursor polymer solutions was further confirmed by 
rheological characterization. Time sweeps and shear moduli measurements revealed rapid 
crosslinking of formulations and G’-G’’ crossovers (that is, the time at which the elastic or solid-
like properties matched the viscous or liquid-like properties of the sample) within several minutes 
after the addition of PEGX (Table 4). Shear moduli were mostly stable by 2 hrs, indicating the 
crosslinking reaction was nearly complete by this time (Figure 1B-E). Final storage and complex 
shear moduli of hydrogels were of similar magnitudes and within the range of 195 to 215 Pa 
(Table 4).  
 
 This narrow range of storage moduli was intended to eliminate hydrogel stiffness as a possible 
confounding factor that could influence cellular response. It has been well-documented that cells 
respond to the mechanical properties of their microenvironment through mechanotransduction[33, 
34]. Substrate stiffness will not only influence endothelial cell morphology and actin stress fiber 
formation[35, 36] but also modulate expression of growth factors and receptor proteins[37]. Ultimately, 
these factors influence endothelial morphogenesis and capillary network formation[35, 38-40]. In 
these investigations, storage moduli of approximately 200 Pa were desired as the BM-like 
archetype Matrigel control has a reported storage modulus of 55 to 90 Pa[28, 41]; however, “soft” 
hydrogel formulations crosslinked via the PEGX method (those with storage moduli below 150 
Pa) previously were shown to degrade rapidly in cell culture conditions[7], so a balance between 
substrate stiffness and rate of degradation was necessary. 
 
 Additional frequency and strain sweeps confirmed the formation of elastic hydrogels after 
crosslinking (Supplemental Figure 3). Interestingly, the hydrogels exhibited strain stiffening 
when exposed to strains between 100% and 1000%. Strain stiffening is a common behavior 
among biological materials, such as fibrin, type I collagen, and kidney decellularized extracellular 
matrix hydrogels, but is typically difficult to recapitulate with synthetic polymer networks[42-44]. 
Although these hydrogels are formed through covalent crosslinks using a synthetic crosslinker, 
the strain-stiffening behavior suggests that interactions between the gelatin polymers such as 
physical associations may still influence the resulting network structure. 
 
 Ultrastructural analysis of hydrogel surfaces via SEM did not demonstrate any considerable 
variation across groups (Figure 2A-D). Swelling analysis of hydrogels, however, revealed a 
distinction between hydrogels without conjugated YIGSR peptide and YIGSR-conjugated 
hydrogels. Investigating the percent weight increase between initial and swollen hydrogel states, 
we found that YIGSR and YIGSR/QK hydrogels tripled in weight (~200% increase) whereas 
hydrogels with no peptides and QK hydrogels only doubled in weight (~100% increase) (Figure 
2E). However, the swelling ratios between swollen hydrogel and dry polymer states was relatively 
similar across groups (Figure 2F). This indicates that this distinction was a result of the increased 
dry polymer weight of YIGSR-conjugated hydrogels, which not only have the addition of the 
YIGSR peptide but also higher concentrations of PEGX (Table 2). To account for this additional 
variable, a scrambled YIGSR peptide control (the RYGSI peptide) previously shown to lack the 
cell-binding activity of the YIGSR peptide[16] was included in later cell studies.  
 
 The VEGF-mimetic QK peptide has been reported to bind VEGF receptors resulting in 
activation of downstream intracellular signaling pathways in endothelial cells, and in particular 
 
2019_PEGX-Gelatin_Peptides_Manuscript_Draft14 
Document Created: 2019-01-19 (JS) 
Last Updated: 2019-01-23 (JS) 
14 
Jimmy Su (JS) 
pathways downstream of VEGFR2[19, 45]. Activation of VEGFR2 leads to dimerization of receptors 
and autophosphorylation of intracellular tyrosine residues[46]. After activation, VEGFR2 is 
internalized during which signaling continues until the receptor is degraded or undergoes 
desphosphorylation and recycling[47]. Importantly, studies suggest that internalization of VEGF 
itself is not necessary for phosphorylation of VEGFR2 and downstream signaling[48]. Therefore, 
utilizing a commercially-available intracellular ELISA kit, we demonstrated that soluble QK peptide 
indeed resulted in significantly elevated levels of phosphorylated VEGFR2 in HUVECs, and this 
activity was preserved even after conjugation to crosslinked gelatin hydrogel substrates using 
PEGX (Figure 3A). 
 
 Surprisingly, this activity did not appear to be consistent between cell types as treatment with 
soluble QK peptide did not result in significant changes in levels of phosphorylated VEGFR2 in 
GEnCs (Figure 3B). In addition, although the treatment of HUVECs with soluble VEGF165 resulted 
in significantly elevated levels of phosphorylated VEGFR2 as expected, this was not the case for 
GEnCs treated for the same duration and with the same concentration of VEGF165. In contrast, 
GEnCs cultured on QK hydrogels exhibited significantly elevated levels of phosphorylated 
VEGFR2. This is particularly intriguing as matrix-bound VEGF has been found to preferentially 
activate VEGFR2 signaling pathways involved in cell migration[49] and result in endothelial vessels 
that are smaller in diameter and contain more branching points in a tumor model[50]. As a 
specialized microvascular endothelial cell population, it is possible that the GEnCs are more 
responsive to matrix-bound VEGF (or in this case, matrix-bound QK peptide) as this would result 
in endothelial structures more reminiscent of microvascular beds. This is further supported by 
knowledge that heparan sulfate proteoglycans within the glomerular basement membrane[51] may 
sequester growth factors with heparin-binding domains, including VEGF165[52, 53]. VEGF165 is the 
predominant VEGF isoform secreted by podocytes[54], the specialized perivascular cells that form 
the external layer of the glomerular filtration barrier, and this VEGF secretion by podocytes is 
crucial in the formation and maintenance of the glomerular filtration barrier[53, 55]. Therefore, these 
results may help tie together the unique physical path and regulation of VEGF within the 
glomerulus: from secretion by podocytes, to sequestration within the glomerular basement 
membrane, and finally presentation to GEnCs. 
 
 HUVECs were employed as readily-available and prototypical cells for investigating 
endothelial cell response to culture on our hydrogel substrates (Figure 4). HUVECs cultured on 
Matrigel rapidly assembled into multicellular, tube-like networks that later regressed into cell 
aggregates, as expected[31, 32]. While HUVECs cultured on hydrogels with no peptides and QK 
hydrogels formed confluent monolayers, HUVECs cultured on YIGSR and YIGSR/QK hydrogels 
formed cord-like structures that persisted throughout the culture period. To our surprise, however, 
HUVECs cultured on RYGSI hydrogel responded in a similar manner forming cord-like structures. 
This suggests that the cord-like structure formation observed was not a result of the bioactivity of 
the YIGSR peptide but instead due to some other factor. Swelling analysis, discussed previously, 
revealed that YIGSR-conjugated hydrogels exhibited greater percent weight increases relative to 
hydrogels with no peptides and QK hydrogels, which is likely an effect of the increased dry 
polymer content of these formulations (Figure 2E-F and Table 2). Therefore, when confined to 
the well dimensions in a cell culture plate, YIGSR-conjugated and similarly RYGSI hydrogels swell 
to a greater extent than hydrogels with no peptides and QK hydrogels, resulting in an uneven 
culture surface or regions of tension and compression that may influence local cellular adhesion 
and migration. 
 
 Gene expression analysis of cultures, however, demonstrated that the addition of conjugated 
bioactive peptides led to changes in expression of many genes of interest in HUVECs (Figure 5). 
In several instances, these changes were upregulated in comparison to culture on hydrogels with 
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no peptides, and ultimately the combined synergistic effects of the peptides in YIGSR/QK 
hydrogels resulted in the highest fold-change expression by day 5. On the other hand, although 
HUVECs formed similar cord-like structures on RYGSI hydrogels, gene expression analysis 
demonstrated that conjugation of the inactive peptide resulted in downregulation of most of the 
genes of interest. This downregulation was often even below expression levels of cells cultured 
on hydrogels with no peptides, which is likely an effect of the increased PEG content of RYGSI 
hydrogels that would alter both the density of available cell-binding sites as well as the swelling 
properties and thus surface topography of the hydrogel substrates. 
 
 Conditionally-immortalized human GEnCs were also employed as an additional cell type for 
investigating endothelial cell response to culture on our hydrogel substrates (Figure 6). GEnCs 
cultured on hydrogels with no peptides formed confluent monolayers, and addition of conjugated 
QK peptide resulted in some cord-like structure formation by cells. While GEnCs cultured on 
YIGSR and YIGSR/QK hydrogels also seemed to form cord-like structures, these structures 
appeared less dense than those formed by HUVECs on the same hydrogel substrates. 
Interestingly, structures formed on RYGSI hydrogels by GEnCs and HUVECs appear more similar 
to each other, which again suggests that the bioactivity of the YIGSR peptide plays an important 
role in modulating cell response. 
  
 Gene expression analysis of cultures likewise demonstrated quite different trends between 
GEnCs and HUVECs (Figure 7). For many genes of interest, the conjugation of bioactive peptides 
did not lead to significant changes in gene expression. Instead, GEnCs exhibited the highest fold-
change expression on Matrigel and RYGSI hydrogels, typically at day 5. Correlating these results 
with images of the cultures, GEnCs seem to prefer extensive cell-cell interactions that form during 
cell aggregation over cell-matrix interactions. This corresponded to upregulation of genes involved 
in cell-cell interactions such as PECAM1 and CDH5, cell surface receptors involved in signaling 
pathways such as KDR and TEK, and endothelial function such as VWF and PVLAP. These 
results reinforce findings from a previous investigation in which GEnCs encapsulated within 
kidney decellularized extracellular matrix hydrogels exhibited lower fold-change expression of 
many of the same genes of interest in comparison to cells encapsulated within type I collagen 
hydrogels in part due to an inability to form strong cell-cell interactions[44].  
 
 The differences in cell response by HUVECs and GEnCs is ultimately not unexpected. 
Endothelial vessels and vascular beds in the body are phenotypically heterogeneous and occupy 
a diverse range of physiological microenvironments[56, 57]. It is not surprising that when isolated 
from an in vivo setting and cultured in vitro, these various cell populations will respond differently. 
For example, Ligresti, et al. isolated human kidney peritubular microvascular endothelial cells 
(HKMECs) and through functional and molecular assays found that these cells lack intrinsic 
regenerative growth capacity and angiogenic potential, which is in contrast to the proliferative 
nature of HUVECs[58]. Further investigations by the same group additionally highlighted the 
distinct responses HKMECs exhibited in comparison to HUVECs when cells were cultured on 
hydrogel substrates composed of type I collagen, kidney cortex decellularized extracellular matrix, 
or a combination of both materials[59]. Similar to these HKMECs, GEnCs are a specialized 
microvascular endothelial cell population isolated from a specific region of the kidney. Therefore, 
it follows that the GEnCs will invariably respond in a much different manner in comparison to 
HUVECs as we have seen from our results. 
 
 Altogether, we have demonstrated the use of the PEGX method to generate stable, 
crosslinked gelatin hydrogels suitable for cell culture. Furthermore, this versatile crosslinking 
method permits the additional conjugation of bioactive peptides to the polymer backbone as a 
strategy to modulate cell response.  Several groups have previously demonstrated a variety of 
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methods for generating peptide-modified PEG hydrogels or PEG-peptide composite hydrogels, 
including mixed mode thiol-acrylate photopolymerization using PEG diacrylate[60], PEG-peptide 
macromers for subsequent photopolymerization using PEG acrylate[61] or PEG diacrylate[62], thiol-
ene photocoupling using PEG-norbornene[63, 64], and self-assembled peptide amphiphile and 
photopolymerizable PEG dimethacrylate composite hydrogels[65]. However, in comparison, the 
synthetic-natural PEG-gelatin composite hydrogels investigated here promote cell adhesion and 
permit cell-mediated degradation even in the absence of additional peptides. This again 
demonstrates the versatility of the PEGX method as demonstrated here and elsewhere[7]. 
 
 Furthermore, unlike the above referenced investigations, the PEGX chemistry utilized in this 
work does not require a photo-mediated reaction and thus eliminates the need for a photoinitiator. 
However, using the specific single SVA-PEG-SVA crosslinker explored in this study, polymer 
crosslinking and conjugation of additional bioactive molecules necessitates increasing the total 
polymer weight of formulations depending on the concentrations of the molecules of interest. This 
can lead to confounding variables such as changes in hydrogel swelling and cell-binding ligand 
densities. Future investigations may opt to explore PEGX physical and chemical variants, such 
as multi-arm PEG crosslinkers[7] or bioorthogonal “click” chemistries[66, 67], to crosslink polymers 
and conjugate multiple bioactive molecules using orthogonal reactions for greater control of 
hydrogel properties. Ultimately, advances in engineering BM-like hydrogel substrates will not only 
enhance physiological understanding of cell-cell and cell-matrix interactions but also accelerate 




 The PEGX method is a versatile crosslinking strategy that, in this study, was used to 
simultaneously generate stable, crosslinked gelatin hydrogels as well as conjugate bioactive 
peptides onto the gelatin polymers. Hydrogels formed from precursor polymer solutions within 
several minutes after the addition of PEGX, but differential swelling properties occurred as a result 
of adjusting peptide and PEGX concentrations. These peptide-conjugated hydrogels were 
investigated as cell culture substrates for two human endothelial cell types, human umbilical vein 
endothelial cells and human glomerular endothelial cells, that exhibited uniquely different cell 
behavior evaluated by measuring levels of phosphorylated VEGFR2 and changes in gene 
expression. Future investigations may explore additional PEGX variants for crosslinking and 
conjugation reactions, a variety of polymers or bioactive molecules for biofunctionalization, or 
other cells types to evaluate cellular response. Ultimately, these studies contribute to the growing 
interest in developing basement membrane-like hydrogels for delineating complex epithelial and 
endothelial cell-cell and cell-matrix interactions. 
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Figures and Figure Captions 
 
 
Scheme 1: Preparation of PEG-crosslinked gelatin hydrogels and conjugation of peptides. 
Gelatin possesses inherent cell-binding sites and free amine reactive groups. When PEGX is 
added to a gelatin solution, the SVA functional groups react with the free amines, forming 
crosslinks between gelatin polymers that results in hydrogel formation. Bioactive peptides 
presenting free amines, such as the YIGSR and QK peptides, can be added to the precursor 
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Figure 1: Quantification of free amine content and rheological time sweeps of hydrogel 
formulations. (A) Free amine content of uncrosslinked hydrogel precursor polymer solutions and 
crosslinked hydrogels quantified by the TNBS assay. Sample groups were normalized to the 
uncrosslinked hydrogel precursor polymer solution with no peptides group (n = 3). Rheological 
characterization of hydrogel formation over time with shear moduli (G’, G’’) plotted on semi-log 
plots: (B) hydrogels with no peptides, (C) QK, (D) YIGSR, and (E) YIGSR/QK hydrogels. Samples 
run in triplicate (n = 3).  
 
 
Figure 2: Scanning electron micrographs and swelling analysis of hydrogels. High-magnification 
scanning electron micrographs of (A) hydrogels with no peptides, (B) QK, (C) YIGSR, and (D) 
YIGSR/QK hydrogels. (E) Percent weight increases from initial to swollen hydrogel states, and 
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Figure 3: Cellular levels of phosphorylated VEGFR2 measured by an ELISA. Phosphorylated 
VEGFR2 in (A) HUVECs and (B) GEnCs following treatment with 100 ng/mL VEGF165 (positive 
control), no treatment (“Ctrl”, negative control), or treatment with 1 µM soluble QK peptide for cells 
cultured on tissue culture polystyrene or hydrogels with no peptides, or no treatment for cells 
cultured on QK hydrogels. Quantification was normalized to the no treatment groups on tissue 
culture polystyrene for each cell type (n = 4). Statistical significance denoted by: * p < 0.05, ** p 
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Figure 4: Photomicrographs of HUVECs cultured on hydrogel substrates at designated time 
points showing formation of cord-like structures that vary with hydrogel formulations. 
 
 
Low PPI figure to reduce file size. 
Figure 5: Gene expression analysis and immunofluorescence staining of HUVECs cultured on 
hydrogel substrates at designated time points. (A) PECAM1 encoding for platelet endothelial cell 
adhesion molecule or CD31. (B) CDH5 encoding for cadherin 5 or vascular endothelial cadherin, 
also known as CD144. (C) ITGB1 encoding for integrin subunit β1. (D) ITGB3 encoding for integrin 
subunit β3. (E) KDR encoding for kinase insert domain receptor or vascular endothelial growth 
factor receptor 2. (F) TEK encoding for tyrosine kinase with immunoglobulin-like and EGF-like 
domains 2 or TIE2. (G) VWF encoding for von Willebrand factor. (H) NOS3 encoding for nitric 
oxide synthase 3. (I) PLVAP encoding for plasmalemma vesicle-associated protein. Values 
presented as fold-change expression normalized to gene expression of HUVECs cultured in 
tissue culture polystyrene on day 0 (n = 4). (J) Whole-mount immunofluorescence staining of 
HUVECs cultured on hydrogel substrates at 6 and 24 hrs. Merged images: PECAM-1 (green), 
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Low PPI figure to reduce file size. 
Figure 6: Photomicrographs of GEnCs cultured on hydrogel substrates at designated time points 
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Figure 7: Gene expression analysis of GEnCs cultured on hydrogel substrates at designated time 
points. (A) PECAM1 encoding for platelet endothelial cell adhesion molecule or CD31. (B) CDH5 
encoding for cadherin 5 or vascular endothelial cadherin, also known as CD144. (C) ITGB1 
encoding for integrin subunit β1. (D) ITGB3 encoding for integrin subunit β3. (E) KDR encoding 
for kinase insert domain receptor or vascular endothelial growth factor receptor 2. (F) TEK 
encoding for tyrosine kinase with immunoglobulin-like and EGF-like domains 2 or TIE2. (G) VWF 
encoding for von Willebrand factor. (H) NOS3 encoding for nitric oxide synthase 3. (I) PLVAP 
encoding for plasmalemma vesicle-associated protein. Values presented as fold-change 
expression normalized to gene expression of GEnCs cultured in tissue culture polystyrene on day 
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Supplemental Figures and Figure Captions 
 
Supplemental Table 1: 
Primer Sequences for Gene Expression Analysis via Real-Time Quantitative Polymerase Chain 
Reaction (RT-qPCR) 
Gene Forward Primer (5' to 3') Reverse Primer (5' to 3') 
PPIA TCG CTC TCT GCT CCT CCT GTT CGA GGC GCC CAA TAC GAC CAA ATC C 
PECAM1 TAT GAT GCC CAG TTT GAG GT GAA TAC CGC AGG ATC ATT TG 
CDH5 TTG GAA CCA GAT GCA CAT TGA T TCT TGC GAC TCA CGC TTG AC 
ITGB1 CCC ACC GTG TTC TTC GAC ATT GGA CCC GTA TGC TTT AGG ATG A 
ITGB3 GTG ACC TGA AGG AGA ATC TGC CCG GAG TGC AAT CCT CTG G 
KDR GTG ATC GGA AAT GAC ACT GGA G CAT GTT GGT CAC TAA CAG AAG CA 
TEK TCC GCT GGA AGT TAC TCA AGA GAA CTC GCC CTT CAC AGA AAT AA 
VWF TGC CTC CAA AGG GCT GTA TC CAC CAC TGT TCT CCA CTG CTC 
NOS3 TGA TGG CGA AGC GAG TGA AG ACT CAT CCA TAC ACA GGA CCC 
PLVAP CTC TTC ATG GTC TAT GGC AAC G GCG AGC ATT CAG CCA CAT C 
 
 
Supplemental Figure 1: Phase plot of varying YIGSR peptide concentrations with varying PEGX 
concentration given that the gelatin concentration is held constant at 5% (m/v). Values in boxes 
are the final storage moduli (in Pa) of indicated formulations as measured by two-hour time 
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Supplemental Figure 2: Photomicrographs of GEnCs cultured for 24 hrs on hydrogel substrates 
of varying combinations and concentrations of YIGSR and QK peptides. Matrigel was included as 
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Supplemental Figure 3: Rheological frequency and strain sweeps of hydrogels. Shear moduli 
(G’, G’’) versus angular frequency plotted on log-log plots: (A) hydrogels with no peptides, (B) QK, 
(C) YIGSR, and (D) YIGSR/QK hydrogels. Dashed lines represent the angular frequency at which 
time sweeps were performed: 10 rad/s. Shear moduli versus strain plotted on log-log plots: (E) 
hydrogels with no peptides, (F) QK, (G) YIGSR, and (H) YIGSR/QK hydrogels. Dashed lines 
represent the strain percent at which time sweeps were performed: 1% strain. 
 
 
Supplemental Figure 4: Low-magnification scanning electron micrographs of hydrogels. 
Scanning electron micrographs of (A) hydrogels with no peptides, (B) QK, (C) YIGSR, and (D) 
YIGSR/QK hydrogels.  
 
